The current study, aimed to illuminate the molecular mechanisms through which the EED-mediated miR-338-5p/METTL3/CDCP1 axis fine-tune the malignant phenotypes of GC cells (Figure 7). This evidence concerns the gene CDCP1 and gastric cancer.